logo2008source

 

contact

 

Lufthansa

 

BAHN

 

TOP

 

PRELIMINARY SCIENTIFIC PROGRAMME


PLENARY LECTURES
MINI LECTURES
SYMPOSIA
LITERATURE UPDATES
COMPACT PRIMERS
PRE-CONGRESS CME COURSES
LATE BREAKING TRIALS
picture
   
PLENARY LECTURES
  
Saturday, June 26th, 2010
 
Eating oneself for immunity and tolerance: the role of autophagy in the immune system
Ludger Klein, Munich, Germany
 
   
Sunday, June 27th, 2010
 
Ciliopathy: from bench to bedside
Gerd Walz, Freiburg, Germany
 
   
Monday, June 28th, 2010
 
Approaches to and biomarkers of transplantation tolerance
Robert Lechler, London, UK
   
return to top
  
MINI LECTURES
   
Basic science
   
Suppressors of cytokine signaling (SOCS) and kidney diseases: a potential novel therapeutic target
Jesus Egido, Madrid, Spain
   
Innate immune responses in ischemia/reperfusion injury
Sandrine Florquin, Amsterdam, Netherlands
   
Dialysis
  
How to assess extracellular volume and “dry weight” in dialysis patients – is bioimpedance the answer?
Adrian Covic, Iasi, Romania
  
Treatment of hypertension in dialysis patients
Olof Heimbürger, Stockholm, Sweden
  
Chronic dialysis since the first month of life: long-term results
Pierre Cochat, Lyon, France
  
Sex differences for chronic kidney disease: a platform for treatment strategies?
Jesus Carrero, Stockholm, Sweden
  
Chronic kidney disease
   
The year after – How do KDIGO CKD-MBD guidelines impact on clinical practice?
Markus Ketteler, Coburg, Germany
  
Body mass index and mortality in dialysis population
Renée de Mutsert, Leiden, Netherlands
   
Sleep disorders in renal patients
Francesca Mallamaci, Reggio Calabria
   
Transplantation
   
Interplay between ischemia/reperfusion injury and alloreactivity
Juan Torras, Barcelona, Spain
  
Optimal preservation for extended criteria kidneys
Rutdger Ploeg, Groningen, The Netherlands
  
Subclinical rejection: to treat or not?
Johan de Fijter, Leiden, Netherlands
   
Transplantation in children with primary hyperoxaluria
Dirk E. Mueller-Wiefel, Hamburg, Germany
   
Acute kidney injury
    
Standard versus intensified dialysis in AKI in intensive care units
Danilo Fliser, Homburg/Saar, Germany
   
Clinical nephrology
  
Novel treatments for ANCA-associated vasculitis
Caroline Savage, Birmingham, UK
  
Proteinuria triggers immune responses
Ariela Benigni, Bergamo, Italy
   
Notch receptors in glomerulonephritis
Peter Mertens, Magdeburg, Germany
   
The role of immunoproteasome in the pathogenesis of IgA nephropathy
Alessandro Amore, Turin, Italy
   
Diabetes
  
Lipid profile and renal function in type 1 diabetes
Nina Tolonen, Helsinki, Finland
  
Inflammation and proteinuria in diabetic patients
Mahmut Ilker Yilmaz, Ankara, Turkey
  
Bone disease
   
CKD-related mineral and bone disorders
Angel Argilés, Montpellier, France
   
The dynamic of PTH secretion in response to calcium; the effect of calcimimetics
Mariano Rodríguez, Córdoba, Spain
   
Hypertension
   
The metabolic syndrome in hypertension
Josep Redon, Valencia, Spain
  
Blood pressure measurement in CKD
Rajiv Agarwal, Indianapolis, USA
   
return to top
   
SYMPOSIA
  
Saturday, June 26th, 2010
   
• Podocytes
- Podocytes - an outside view of the glomerulus
Agnes Fogo, Nashville, USA
- Podocytes regeneration
Paola Romagnani, Florence, Italy
- The role of parietal cells in health and disease
Marcus J. Moeller, Aachen, Germany
- Transcription factors as therapeutic targets in podocytes
Peter Mathieson, Bristol, UK
  
• Pathophysiology of AKI
- Hypoxia and renal injury
Michael S. Wiesener, Erlangen, Germany
- TWEAK/FN14 in acute kidney injury
Alberto Ortiz, Madrid, Spain
- Inflammatory mechanisms in AKI
Marc De Broe, Antwerp, Belgium
- Monocytes derived cells in acute kidney injury
Jeremy Hughes, Edinburg, UK
  
• Registry
- EVEREST - factors affecting RRT incidence and treatment modality choice
Fergus Caskey, Bristol, United Kingdom
- EVEREST - factors affecting patient survival
Anneke Kramer, Amsterdam, The Netherlands
- Haemodialysis-Peritoneal dialysis comparisons
Moniek van de Luijtgaarden, Amsterdam, The Netherlands
- Trends in access to transplantation
Vianda Stel, Amsterdam, The Netherlands
- The complementary use of Registry data for research into rare diseases
Cristoph Wanner, Würzburg, Germany
  
• Nephrolithiasis and nephrocalcinosis
- Nephrocalcinosis: new insights into mechanisms and consequences
Benjamin A. Vervaet, Antwerp, Belgium
- Calcium receptors in mineral ion transport
Giuseppe Vezzoli, Rome, Italy
- Management of hypercalciuria
Andrew Schwaderer, Ohio, USA
- Non-drug induced nephrotoxicity
Justine Bacchetta, Bron, France
   
• Focal segmental glomerulosclerosis
- Advanced glycation end-products in diabetic nephropathy: suppression of neutropilin expression to promote focal glomerulosclerosis
Gunter Wolf, Jena, Germany
- Cardiotrophin-like cytokine-1, potential FSGS permeability factor
Virginia J. Savin, Milwaukee, USA
- Discovery of MYH9 genetic variations and advanced focal segmental glomerular sclerosis
Rulan S. Parekh, Toronto, Canada
- Update on the treatment of idiopathic FSGS
Alain Meyrier, Paris, France
  
• Peritoneal Dialysis 1
- Dynamic interactions between peritoneum and abdominal adipocytes: the effect of peritoneal dialysis solutions
Daniel Teta, Lausanne, Switzerland
- Peritoneal functional pathology: the role of immunohistochemistry in the understanding of peritoneal pathophysiology
José Jiménez-Heffernan, Madrid, Spain
- Pathophysiology of the peritoneal interstitium and mesothelial cells in ultrafiltration failure (UFF)
Bengt Rippe, Lund, Sweden
- Biomarkers in peritoneal dialysis
Raymond T. Krediet, Amsterdam, Netherlands
 
• Cardiovascular risk biomarkers
- Biomarkers: when is it justified to incorporate a new biomarker into clinical practice?
Carmine Zoccali, Reggio Calabria, Italy
- Inflammation in chronic kidney disease. Etiology, prognosis and treatment
Peter Stenvinkel, Stockholm, Sweden
- Cardiac natriuretic peptides and risk stratification in CKD
Christiane Drechsler, Würzburg, Germany
- Cardiovascular risk biomarkers in renal transplantation
Didier Ducloux, Besançon, France
 
• KDIGO Symposium: guidelines in AKI
 
• Protein bound uremic toxins
- Metabolism
Raymond Vanholder, Gent, Belgium
- Biological effects
Joachim Jankowski, Berlin, Germany
- Removal of protein bound toxins by hemodialysis
Horst-Dieter Lemke, Obernburg, Germany
- New insights from clinical studies
Ziad Massy, Amiens, France
 
• Renal transplantation: Clinical Pharmacology
- Impact of pharmacogenetic testing on dosing of immunosuppressive drugs
Teunis van Gelder, Rotterdam, Netherlands
- Optimization of immunosuppressants dosing in renal transplantation
Yannick Le Meur, Limoges, France
- Genome wide analysis and transplantation: what is it and what could it bring us?
Dirk R. Kuypers, Louvain, Belgium
- Population pharmacokinetics in renal transplantation
Manuel Oriol, Lausanne, Switzerland
 
The bone (adipocyte) vascular axis
- Klotho, FGF23 and vitamin D: a bone-kidney story and much more
Gérard Friedlander, Paris, France
- Beyond Ca/P/PTH: clinical evidence of a link between the adipose tissue and bone disease in ESRD
Andrzej Wiecek, Katowice, Poland
- Vascular calcifications as a risk factor for cardiovascular mortality
Leon Schurgers, Maastricht, Netherlands
- Vascular calcification: can we control progression and regression?
Jorge B. Cannata-Andía, Oviedo, Spain
 
• Cell-driven renal repair
- Stem cells and renal regeneration
Uta Kunter, Aachen, Germany
- Mesenchymal stem cells in organ transplantation
Federica Casiraghi, Bergamo, Italy
- Potential repairing process of renal progenitor cells in tubular damage
Francesco Paolo Schena, Bari, Italy
- Stem cells and whole organ scaffolds: implications for kidney regenerative medicine
Edward A. Ross, Gainesville, USA
  
• IgA nephropathy
- Oxidative stress modulates the nephrotoxicity of aberrantly glycosylated IgA1
Rosanna Coppo, Turin, Italy
- C4d deposition in IgA nephropathy
Mario Espinosa, Córdoba, Spain
- Renal biopsy in IgA nephropathy: the Oxford classification and beyond
Ian Roberts, Oxford, UK
- IgA nephropathy: a review of recent and ongoing treatment studies
Claudio Pozzi, Cinisello Balsamo, Italy
 
• Haemodialysis
- Biocompatibility and genomics in dialysis
Rainer Oberbauer, Linz, Austria
- Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function
Tienush Rassaf, Düsseldorf, Germany
- Impact of a haemodialysis session for myocardial perfusion
Christoph W. McIntyre, Derby, Uk
- Arrhythmias in dialysis patients
Walter H. Hörl, Vienna, Austria
  
• Role of physical fitness in CKD patients
- Physical fitness - an integral part of comprehensive care of CKD patients
Rolfdieter Krause, Berlin, Germany
- The effects of exercise training on muscle with special reference to patients with CKD
Tom Mercer, Edinburgh, United Kingdom
- The impact of physical fitness on morbidity and quality of life in patients with CKD
Kirsten Anding-Rost, Bischofswerda, Germany
  
• European Cardiovascular and Renal Medicine (EURECAM)
- EURECAM mission and results of surveys
Carmine Zoccali, Reggio Calabria, Italy
- The potential of Registries for scientific research in Cardiovascular and Renal Medicine
Friedo W. Dekker, Leiden, The Netherlands
- Information provided by 24 h ambulatory blood pressure monitoring
Gianfranco Parati, Milan, Italy
- Potential and caveats on the use of Clinical Trials data-bases for secondary analyses in Cardiovascular and Renal Medicine
Johannes Mann, Munich, Germany
 
• Hypertension
- Aldosterone-receptor antagonism in hypertension: where do we stand
Anton H. van den Meiracker, Rotterdam, The Netherlands
- Is aldosterone toxic for renal cells?
Eric Féraille, Geneva, Switzerland
- Arterial stiffness in renal transplant recipients
Francis Verbeke, Ghent, Belgium
- Can we treat arterial stiffness?
Stéphane Laurent, Paris, France
  
• ERA-EDTA Nephroquest Working Group
 
  
Sunday, June 27th, 2010
  
• Renal transplantation: the humoral barrier
- ABO incompatible renal transplantation
Marcel Geyer, Freiburg, Germany
- Prevention and treatment of antibody-mediated rejection
Denis Glotz, Paris, France
- The role of costimulatory signals in antibody-mediated rejection
Suzanne T. Ildstad, Louisville
- Novel therapies to inhibit humoral responses: the role of proteosome inhibition
Flavio Vincenti, San Francisco, USA
  
• Is cardiorenal syndrome a new entity?
- Pro
Claudio Ronco, Vicenza, Italy
- Con
Walter H. Hörl, Vienna, Austria
- Impact of various manifestations of renal dysfunction on heart failure
Gerjan Navis, Groningen, The Netherlands
- Continuous extracorporeal treatments in heart failure
Giancarlo Marenzi, Milan, Italy
    
• Renal physiology
- Renal and extrarenal effects of Klotho
Florian Lang, Tübingen, Germany
- Novel genetic disorders of nephron function
Robert Kleta, London, UK
- Novel aspects of the renin-angiotensin-system
Armin Kurtz, Regensburg, Germany
- Novel aspects of sodium resorption and storage
Jens Titze, Erlangen, Germany
     
• Outcomes in renal transplantation
- Current impact of HLA compatibility and immunosuppression on graft survival
Gerhard Opelz, Heidelberg, Germany
- Long-term outcomes of the European Senior Program
Urlich Frei, Berlin, Germany
- Sustained improvement of graft survival: is it feasible?
Josep M. Campistol, Barcelona, Spain
   
• Sympathetic overactivity in hypertension and in CKD
- The pathogenesis and clinical relevance of sympathetic hyperactivity in chronic kidney disease
Peter J. Blankestijn, Utrecht, Netherlands
- Pharmacologic interference with the sympathetic system in cardiovascular and renal diseases
Guido Grassi, Monza, Italy
- Renal sympathetic denervation in resistant hypertension in humans
Henry Krum, Melbourne, Australia
    
• New insights into rare CKD-associated diseases
- Calciphylaxis
Vincent Brandenburg, Aachen, Germany
- Encapsulating peritoneal sclerosis
Angela M. Summers, Manchester, UK
- Nephrogenic systemic fibrosis
Andreas Kribben, Essen, Germany
    
• Immune mechanisms in autoimmune nephritis
- Pseudoviral immunity. The novel concept of immunity
Hans Joachim Anders, Munich, Germany
- The TH1 and TH17 immune response in Glomerulonephritis
Oliver Steinmetz, Hamburg, Germany
- Novel roles of chemokines
Carla Zoja, Bergamo, Italy
    
• When to start dialysis
- Ideal time for starting renal replacement therapy
Friedo W. Dekker, Leiden, Netherlands
- Unplanned start on assisted peritoneal dialysis
Johan Vestergaard Povlsen, Aarhus, Denmark
- Which role for incremental peritoneal dialysis
Giusto Viglino, Alba, Italy
   
• Progression of renal damage
- Controlling transglutaminase type 2 prevents the progression of chronic kidney disease
Timothy S. Johnson, Sheffield, UK
- Capillary rarefication, angiogenesis and VEGF in the progression of renal disease
Gert Mayer, Innsbruck, Austria
- Danger-associated molecular pattern (DAMP) molecules in progressive renal disease
Detlef O. Schlöndorff, New York, USA
- Growth factors in renal regeneration
Josep M. Cruzado, Barcelona, Spain
    
• KDIGO on management of glomerular diseases
- Introduction
John Feehally, Leicester, UK
- Treatment of Minimal change nephropathy and FSGS
Jack S.M. Wetzels, Nijmegen, The Netherlands
- IgA nephropathy
Jürgen Floege, Aachen, Germany
- Membranous and membranoproliferative glomerulonephritis
Richard Glassock, Los Angeles, USA
- Lupus and vasculitis
Fernando Fervenza, Rochester, USA
   
• Peritoneal dialysis 2
- Multicenter experience with low-sodium peritoneal dialysis solutions
Simon Davies, Stoke-on-Trent, UK
- PDGF in renal and peritoneal fibrosis
Peter Margetts, Ontario, Canada
- Peritoneal infection/inflammation and patient outcomes: data from the GLOBAL fluid study
Nick Topley, Cardiff, UK
- Current outcomes in peritoneal dialysis
Giovanni Cancarini, Brescia, Italy
   
• Prevention of cardiovascular risk in renal patients
- Nutritional initiatives to decrease cardiovascular risk in CKD
Michal Chmielewski, Gdansk, Poland
- Limitations of statins in the prevention of cardiovascular events in dialysis patients
Bengt Fellstrom, Uppsala, Sweden
- Effect of blood pressure lowering on cardiovascular morbidity and mortality in   people with chronic kidney disease
Hiddo J. Lambers Heerspink, Groningen, The Netherlands
- Atherosclerosis and vascular calcification and CKD - Insights from animal models
Ziad A. Massy, Amiens, France
    
• Transplantation: New immunosuppressants
- Jak-3 inhibitors
Willem Weimar, Rotterdam, Netherlands
- Costimulatory signal blockers
Thomas Wekerle, Vienna, Austria
- Is there a role for new anti-B cells and anti-complement agents in kidney transplant patients?
Lionel Rostaing, Toulouse, France
- Novel therapies to inhibit adhesion and coactivation pathways
Flavio Vincenti, San Francisco, USA
   
• Ciliopathies
- Signaling pathways and function of primary cilia
Søren Tvorup Christensen, Copenhagen, Denmark
- The dynamic cilium in human diseases: the example of the OFDI syndrome
Brunella Franco, Naples, Italy
- How animal models for PKD mimic human disease
Albert Ong, Sheffield, UK
- Restoration of renal function in animal models of ciliopathies
Jonathan L. Tobin, London, United Kingdom
  
• Immunonephrology
- Organization and activities of the Immunonephrology Working Group
Mohamed R. Daha, Leiden, The Netherlands
- Proposal from the group: validation study of the clinico-pathological classification of IgAN in Europe
Rosanna Coppo, Turin, Italy
- Proposals of new collaborative studies on rare diseases and recurrent glomerular diseases after transplantation
Jürgen Floege, Aachen, Germany
- Fair of scientific ideas
Loreto Gesualdo, Foggia, Italy
    
Monday, June 28th, 2010
 
• T regulatory cells in renal transplantation
- T regulatory cells in alloimmune response
Kathryn Wood, Oxford, UK
- Mastering Treg function to promote tolerance
Angus W. Thomson, Pittsburgh, USA
- Adoptive cell therapy with regulatory T cells in renal transplantation
Giovanna Lombardi, London, UK
- Intragraft T regulatory cells in kidney transplantation
Oriol Bestard, Barcelona, Spain
   
• ERBP
- ERBP as the current guidance body of European nephrology: current status
Raymond Vanholder, Ghent, Belgium
- ERBP position statement on choice of hemodialysis membranes
James Tattersall, Leeds, UK
- ERBP position statement on the KDIGO CKD-MBD guidelines
Gérard London, Fleury-Mérogis, France
- ERBP position statement on prevention and treatment of central vein hemodialysis catheters
Raymond Vanholder, Ghent, Belgium
- ERBP advice on testing of peritoneal membrane quality
Wim Van Biesen, Ghent, Belgium
   
• Treatment of glomerular diseases
- Multitarget therapy for lupus nephritis
David Jayne, Cambridge, UK
- Current therapies in membranous nephropathy
José Ballarin, Barcelona, Spain
- Outcomes of recent trials in ANCA-associated vasculitis
Kirsten de Groot, Offenbach, Germany
- Complement regulation and haemolytic uremic syndrome
David Kavanagh, Newcastle, UK
   
• Anaemia in CKD
- Haemoglobin variability in non-dialysis CKD patients
A.L.M de Francisco, Santander, Spain
- Hepcidin levels and erythropoietin response in CKD patients
Damien R. Ashby, London, UK
- Modifying iron balance in CKD patients, is BMP signalling a reasonable target?
Donal Reddan, Galway, Ireland
- Anaemia management in patients with CKD: European Best Practice    recommendations
Francesco Locatelli, Lecco, Italy
  
• Tubular transport
- Calcium in motion: from renal transporters to new concepts
René Bindels, Nijmegen, The Netherlands
- Distal tubular potassium channels and renal salt wasting
Richard Warth, Regensburg, Germany
- The epithelial sodium channel (ENaC) and its role in arterial hypertension and renal sodium retention
Cristoph Korbmacher, Erlangen, Germany
- Amino acid transport
François Verrey, Zürich, Switzerland
    
• Endothelin and endothelin-receptor antagonists
- Pathophysiology of the endothelin system: lessons from genetically manipulated      animals models
Berthold Hocher, Berlin, Germany
- Endothelin-1 and its antagonism in chronic kidney disease
Neeraj Dhaun, Edinburgh, UK
- Endothelin receptor antagonists in diabetic nephropathy
René R. Wenzel, Zell am See, Austria
   
• The bone and CKD
- The culprit of osteoporosis in CKD
Marie-Hélène Lafage-Proust, Saint-Etienne, France
- Calcium metabolism changes after transplantation
Pieter Evenepoel, Leuven, Belgium
- Adynamic bone disease: from bone to vessels
Jordi Bover, Barcelona, Spain
   
• Nephroprotection
- Screening for albuminuria in the prevention of renal function loss
Ronald T. Gansevoort, Groningen, Netherlands
- RAAS blockade in native and grafted kidneys
Leszek Tylicki, Gdansk, Poland
- Pleiotropic effects of ATR1 blockers
Giuseppe Remuzzi, Bergamo, Italy
   
• Regulatory aspects of kidney function
- (Patho)physiology of intercalated cells
Carsten Wagner, Zürich, Switzerland
- The serum and glucocorticoid inducible kinase SGK1 in the regulation of renal    function and blood pressure
Florian Lang, Tübingen, Germany
- Impact of trans- and paracellular permeability
Markus Bleich, Kiel, Germany
  
return to top
   
LITERATURE UPDATES
   
Saturday, June 26th, 2010
  
• Clinical nephrology
- Optimal management of hypertension
Giuseppe Mancia, Milan, Italy
- Side effects in treatment in nephrology
David Jayne, Cambridge, UK
- Therapy of glomerular diseases
Alan Salama, London, UK
   
• Transplantation
- Renal preservation
Speaker to be confirmed
- Immunosuppression
Uwe Heemann, Munich, Germany
- Polyomavirus infection in renal transplantation
Cristina Costa, Turin, Italy
- Recurrent renal diseases
Pierre Cochat, Lyon, France
 
      
Sunday, June 27th, 2010
 
• Dialysis
- Fluid balance and core temperature control to improve hemodynamic stability
Speaker to be confirmed
- Diffusive and convective toxin removal by dialysis procedures
Detlef Krieter, Würzburg, Germany
- Vaccination and hygiene strategies for infection prevention
Michel Jadoul, Louvain, Belgium
- Oxidative stress in dialysis patients: causes and consequences.
Jan Kielstein, Hannover, Germany
 
return to top
 
COMPACT PRIMERS
   
Sunday, June 27th, 2010
 
• Treatment of AKI in special populations
- Renal transplantation
Christophe Legendre, Paris, France
- AKI in children
Franz Schaefer, Heidelberg, Germany
- AKI in HIV-infected patients
Paul L. Kimmel, Washington, USA
- Treatment of AKI in oncology patients
Claudio Ronco, Vicenza, Italy
   
• Practices in renal transplantation
- Cardiovascular screening of potential transplant recipients
Alan G. Jardine, Glasgow, UK
- Sense or non sense of screening transplant recipients for malignancies
Bryce Kiberd, Halifax, Canada
- Pregnancy in transplant donors
Anna Varberg Reisaeter, Oslo, Norway
- Donor registries: the common Living Donor Database within Scandinavia
Ole Oyen, Oslo, Norway
 
  
Monday, June 28th, 2010
 
• Peritoneal dialysis in special patients
- Volume in PD: the heart of the matter
Wim van Biesen, Ghent, Belgium
- Peritoneal dialysis in cirrhotic patients: effects on portal hypertension
Rafael Selgas, Madrid, Spain
- Optimal use of peritoneal dialyis in diabetic patients
Francisco Coronel, Madrid, Spain
   
return to top
   
PRE-CONGRESS CME COURSES
 
Friday, June 25th, 2010
 
Animal models of renal diseases
   
• Transplant immunology
  
Renal ultrasonography
   
Omics in Nephrology
   
Rheumatology for nephrologists
 
Sunday, June 27th, 2010
 
Rare renal diseases
    
return to top
  
LATE BREAKING TRIALS
 
Saturday, June 26th, 2010
• Late breaking trials 1
 
Sunday, June 27th, 2010
• Late breaking trials 2
 
return to top

 

Il contenuto di questa pagina richiede una nuova versione di Adobe Flash Player.

Scarica Adobe Flash Player

era-edta

DGfn